Ning, Jian-Fang <br/><br/>
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma.  [electronic resource] 

 -  Nature communications  07 2019 
 - 2910 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-019-10993-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Surface--genetics<br/>Ataxia Telangiectasia Mutated Proteins--genetics<br/>Cell Cycle Proteins--genetics<br/>Cyclin-Dependent Kinases--genetics<br/>Drug Resistance, Neoplasm<br/>Female<br/>Glioblastoma--drug therapy<br/>Homologous Recombination<br/>Humans<br/>Mice<br/>Mice, SCID<br/>N-Myc Proto-Oncogene Protein--genetics<br/>Neoplastic Stem Cells--metabolism<br/>Poly (ADP-Ribose) Polymerase-1--genetics<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Protein Binding<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Xenograft Model Antitumor Assays